Benjamin Engelhardt
Ludwigshafen Am Rhein, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Population Pharmacokinetics and Exposure-Response Analyses to Support Cofetuzumab Pelidotin (ABBV-647) Dose Optimization in Non-Small Cell Lung Cancer Patients.
Journal: Clinical pharmacology and therapeutics
Published: April 14, 2026
Semi-Mechanistic PK/PD Modeling of Platelets and Spleen Volume With Navitoclax in Combination With Ruxolitinib in Patients With Myelofibrosis.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 12, 2026
Population Pharmacokinetics and Exposure-Response Analyses for Telisotuzumab Vedotin in Patients With c-Met Protein Overexpressing Tumors.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 29, 2026
Semi-mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine.
Journal: CPT: pharmacometrics & systems pharmacology
Published: May 02, 2024
Dosing of Venetoclax in Pediatric Patients with Relapsed Acute Myeloid Leukemia: Analysis of Developmental Pharmacokinetics and Exposure-Response Relationships.
Journal: Clinical therapeutics
Published: April 29, 2024
Exposure-response relationships of venetoclax in combination with carfilzomib and dexamethasone in relapsed/refractory t(11;14) multiple myeloma patients.
Journal: Investigational new drugs
Published: February 19, 2024
Use of Clinical Trial Simulations to Compare the Performance of Different Approaches for Population Analyses of Pediatric Pharmacokinetic Data.
Journal: Journal of clinical pharmacology
Published: October 20, 2022
Upadacitinib pharmacokinetics and exposure-response analyses of efficacy and safety in psoriatic arthritis patients - Analyses of phase III clinical trials.
Journal: Clinical and translational science
Published: May 19, 2021
Model Informed Dosing Regimen and Phase I Results of the Anti-PD-1 Antibody Budigalimab (ABBV-181).
Journal: Clinical and translational science
Published: April 09, 2020
SEEDS: data driven inference of structural model errors and unknown inputs for dynamic systems biology.
Journal: Bioinformatics (Oxford, England)
Published: March 30, 2020
A Bayesian approach to estimating hidden variables as well as missing and wrong molecular interactions in ordinary differential equation-based mathematical models.
Journal: Journal of the Royal Society, Interface
Published: May 08, 2017
Last Updated: 09/26/2026